Pyrazinamide susceptibility testing of Mycobacterium tuberculosis by high resolution melt analysis

Tuberculosis

Volumn 94, Issue 1, 2014, Pages 20-25

  Pholwat, Suporn ^a   Stroup, Suzanne ^a   Gratz, Jean ^a   Trangan, Varittha ^b   Foongladda, Suporn ^b   Kumburu, Happiness ^c   Juma, Saumu Pazia ^c   Kibiki, Gibson ^c   Houpt, Eric ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b MAHIDOL UNIVERSITY   (Thailand)

^c KILIMANJARO CLINICAL RESEARCH INSTITUTE   (Tanzania)

Author keywords

Genotypic; High resolution melt; MDR TB; Pyrazinamide

Indexed keywords

PYRAZINAMIDE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; GENE MUTATION; GENE SEQUENCE; HIGH RESOLUTION MELTING ANALYSIS; INTERMETHOD COMPARISON; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHENOTYPE; PNCA GENE; PNCA1 GENE; PNCA2 GENE; PNCA3 GENE; PNCA4 GENE; PNCA5 GENE; PNCA6 GENE; PNCA7 GENE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; WILD TYPE;

GENOTYPIC; HIGH RESOLUTION MELT; MDR-TB; PYRAZINAMIDE;

ADOLESCENT; ADULT; AGED; AMIDOHYDROLASES; ANTITUBERCULAR AGENTS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GENOTYPE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MUTATION; MYCOBACTERIUM TUBERCULOSIS; POPULATION SURVEILLANCE; PYRAZINAMIDE; REAL-TIME POLYMERASE CHAIN REACTION; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84891558600     PISSN: 14729792     EISSN: 1873281X     Source Type: Journal    
DOI: 10.1016/j.tube.2013.10.006     Document Type: Article

References (37)

1. L. Heifets, and P. Lindholm-Levy Pyrazinamide sterilizing activity in vitro against semidormant Mycobacterium tuberculosis bacterial populations Am Rev Respir Dis 145 1992 1223 1225 10.1164/ajrccm/145.5.1223
2. I. Sanchez-Albisua, M.L. Vidal, G. Joya-Verde, F. del Castillo, M.I. de Jose, and J. Garcia-Hortelano Tolerance of pyrazinamide in short course chemotherapy for pulmonary tuberculosis in children Pediatr Infect Dis J 16 1997 760 763 (Pubitemid 27364787)
3. Clinical trial of six-month and four-month regimens of chemotherapy in the treatment of pulmonary tuberculosis: the results up to 30 months Tubercle 62 1981 95 102
4. D.E. Snider Jr., J. Rogowski, M. Zierski, E. Bek, and M.W. Long Successful intermittent treatment of smear-positive pulmonary tuberculosis in six months: a cooperative study in Poland Am Rev Respir Dis 125 1982 265 267 (Pubitemid 12177794)
5. M.M. Hannan, E.P. Desmond, G.P. Morlock, G.H. Mazurek, and J.T. Crawford Pyrazinamide-monoresistant Mycobacterium tuberculosis in the United States J Clin Microbiol 39 2001 647 650 10.1128/Jcm.39.2.647-650.2001 (Pubitemid 32150834)
6. R. Tasneen, S.Y. Li, C.A. Peloquin, D. Taylor, K.N. Williams, K. Andries, K.E. Mdluli, and E.L. Nuermberger Sterilizing activity of novel TMC207- and PA-824-containing regimens in a murine model of tuberculosis Antimicrob Agents Chemother 55 2011 5485 5492 10.1128/AAC.05293-11 AAC.05293-11 [pii]
7. K.D. Stottmeier, R.E. Beam, and G.P. Kubica Determination of drug susceptibility of mycobacteria to pyrazinamide in 7H10 agar Am Rev Respir Dis 96 1967 1072 1075
8. C. Scarparo, P. Ricordi, G. Ruggiero, and P. Piccoli Evaluation of the fully automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide, streptomycin, isoniazid, rifampin, and ethambutol and comparison with the radiometric BACTEC 460TB method J Clin Microbiol 42 2004 1109 1114 10.1128/Jcm.42.3.1109-1114.2004 (Pubitemid 38332833)
9. P. Chedore, L. Bertucci, J. Wolfe, M. Sharma, and F. Jamieson Potential for erroneous results indicating resistance when using the Bactec MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide J Clin Microbiol 48 2010 300 301 10.1128/Jcm.01775-09
10. C. Piersimoni, A. Mustazzolu, F. Giannoni, S. Bornigia, G. Gherardi, and L. Fattorini Prevention of false resistance results obtained in testing the susceptibility of Mycobacterium tuberculosis to pyrazinamide with the Bactec MGIT 960 system using a reduced inoculum J Clin Microbiol 51 2013 291 294 10.1128/Jcm.01838-12
11. Y. Zhang, and D. Mitchison The curious characteristics of pyrazinamide: a review Int J Tuberc Lung D 7 2003 6 21 (Pubitemid 36427026)
12. G.P. Morlock, J.T. Crawford, W.R. Butler, S.E. Brim, D. Sikes, G.H. Mazurek, C.L. Woodley, and R.C. Cooksey Phenotypic characterization of pncA mutants of Mycobacterium tuberculosis Antimicrob Agents Chemother 44 2000 2291 2295 10.1128/Aac.44.9.2291-2295.2000 (Pubitemid 30650870)
13. S. Sreevatsan, X. Pan, Y. Zhang, B.N. Kreiswirth, and J.M. Musser Mutations associated with pyrazinamide resistance in pncA of Mycobacterium tuberculosis complex organisms Antimicrob Agents Chemother 41 1997 636 640 (Pubitemid 27098417)
14. A. Scorpio, P. LindholmLevy, L. Heifets, R. Gilman, S. Siddiqi, M. Cynamon, and Y. Zhang Characterization of pncA mutations in pyrazinamide- resistant Mycobacterium tuberculosis Antimicrob Agents Chemother 41 1997 540 543 (Pubitemid 27098400)
15. F. Brossier, N. Veziris, V. Jarlier, and W. Sougakoff Performance of MTBDR plus for detecting high/low levels of Mycobacterium tuberculosis resistance to isoniazid Int J Tuberculosis Lung Dis The Official J Int Union Against Tuberculosis Lung Dis 13 2009 260 265
16. K. Ajbani, C. Nikam, M. Kazi, C. Gray, C. Boehme, K. Balan, A. Shetty, and C. Rodrigues Evaluation of genotype MTBDRsl assay to detect drug resistance associated with fluoroquinolones, aminoglycosides and ethambutol on clinical sediments PLoS One 7 2012 10.1371/journal.pone.0049433 ARTN e49433
17. P. Jureen, J. Werngren, and S.E. Hoffner Evaluation of the line probe assay (LiPA) for rapid detection of rifampicin resistance in Mycobacterium tuberculosis Tuberculosis 84 2004 311 316 10.1016/j.tube.2003.12.001 (Pubitemid 38858117)
18. A.M. Mohamed, D.R. Bastola, G.P. Morlock, R.C. Cooksey, and S.H. Hinrichs Temperature-mediated heteroduplex analysis for detection of pncA mutations associated with pyrazinamide resistance and differentiation between Mycobacterium tuberculosis and Mycobacterium bovis by denaturing high-performance liquid chromatography J Clin Microbiol 42 2004 1016 1023 10.1128/Jcm.42.3.1016-1023.2004 (Pubitemid 38332819)
19. J. Sekiguchi, T. Nakamura, T. Miyoshi-Akiyama, F. Kirikae, I. Kobayashi, E. Augustynowicz-Kopec, Z. Zwolska, K. Morita, T. Suetake, H. Yoshida, S. Kato, T. Mori, and T. Kirikae Development and evaluation of a line probe assay for rapid identification of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis strains J Clin Microbiol 45 2007 2802 2807 10.1128/JCM.00352-07 (Pubitemid 47417318)
20. S. Mitarai, S. Kato, H. Ogata, A. Aono, K. Chikamatsu, K. Mizuno, E. Toyota, A. Sejimo, K. Suzuki, S. Yoshida, T. Saito, A. Moriya, A. Fujita, S. Sato, T. Matsumoto, H. Ano, T. Suetake, Y. Kondo, T. Kirikae, and T. Mori Comprehensive multicenter evaluation of a new line probe assay kit for identification of mycobacterium species and detection of drug-resistant Mycobacterium tuberculosis J Clin Microbiol 50 2012 884 890 10.1128/JCM.05638-11
21. S. Chakravorty, H. Kothari, B. Aladegbami, E.J. Cho, J.S. Lee, S.S. Roh, H. Kim, H. Kwak, E.G. Lee, S.H. Hwang, P.P. Banada, H. Safi, L.E. Via, S.N. Cho, C.E. Barry, and D. Alland Rapid, high-throughput detection of rifampin resistance and heteroresistance in Mycobacterium tuberculosis by use of sloppy molecular beacon melting temperature coding J Clin Microbiol 50 2012 2194 2202 10.1128/Jcm.00143-12
22. S. Chakravorty, B. Aladegbami, K. Thoms, J.S. Lee, E.G. Lee, V. Rajan, E.J. Cho, H. Kim, H. Kwak, N. Kurepina, S.N. Cho, B. Kreiswirth, L.E. Via, C.E. Barry, and D. Alland Rapid detection of fluoroquinolone-resistant and heteroresistant Mycobacterium tuberculosis by use of sloppy molecular beacons and dual melting-temperature codes in a real-time PCR assay J Clin Microbiol 49 2011 932 940 10.1128/Jcm.02271-10
23. J.E. Rice, A.H. Reis, L.M. Rice, R.K. Carver-Brown, and L.J. Wangh Fluorescent signatures for variable DNA sequences Nucleic Acids Res 40 2012 10.1093/nar/gks731 ARTN e164
24. M. Slany, M. Vanerkova, E. Nemcova, B. Zaloudikova, F. Ruzicka, and T. Freiberger Differentiation of staphylococcus spp. by high-resolution melting analysis Can J Microbiol 56 2010 1040 1049 10.1139/W10-091
25. S. Merchant-Patel, P.J. Blackall, J. Templeton, E.P. Price, S.Y.C. Tong, F. Huygens, and P.M. Giffard Campylobacter jejuni and Campylobacter coli genotyping by high-resolution melting analysis of a flaA fragment Appl Environ Microb 76 2010 493 499 10.1128/Aem.01164-09
26. A. Kovanda, and M. Poljak Real-time polymerase chain reaction assay based on high-resolution melting analysis for the determination of the rs12979860 polymorphism involved in hepatitis C treatment response J Virol Methods 175 2011 125 128 10.1016/j.jviromet.2011.04.018
27. G.E. Choi, S.M. Lee, J. Yi, S.H. Hwang, H.H. Kim, E.Y. Lee, E.H. Cho, J.H. Kim, H.J. Kim, and C.L. Chang High-resolution melting curve analysis for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical isolates J Clin Microbiol 48 2010 3893 3898 10.1128/JCM.00396-10
28. M.V. Ramirez, K.C. Cowart, P.J. Campbell, G.P. Morlock, D. Sikes, J.M. Winchell, and J.E. Posey Rapid detection of multidrug-resistant Mycobacterium tuberculosis by use of real-time PCR and high-resolution melt analysis J Clin Microbiol 48 2010 4003 4009 10.1128/JCM.00812-10
29. X. Chen, F. Kong, Q. Wang, C. Li, J. Zhang, and G.L. Gilbert Rapid detection of isoniazid, rifampin, and ofloxacin resistance in Mycobacterium tuberculosis clinical isolates using high-resolution melting analysis J Clin Microbiol 49 2011 3450 3457 10.1128/JCM.01068-11
30. A.S. Lee, D.C. Ong, J.C. Wong, G.K. Siu, and W.C. Yam High-resolution melting analysis for the rapid detection of fluoroquinolone and streptomycin resistance in Mycobacterium tuberculosis PLoS One 7 2012 e31934 10.1371/journal.pone.0031934
31. F. Wang, H. Shen, M. Guan, Y. Wang, Y. Feng, X. Weng, H. Wang, and W. Zhang High-resolution melting facilitates mutation screening of rpsL gene associated with streptomycin resistance in Mycobacterium tuberculosis Microbiol Res 166 2011 121 128 10.1016/j.micres.2010.02.001
32. P.J. Campbell, G.P. Morlock, R.D. Sikes, T.L. Dalton, B. Metchock, A.M. Starks, D.P. Hooks, L.S. Cowan, B.B. Plikaytis, and J.E. Posey Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis Antimicrob Agents Chemother 55 2011 2032 2041 10.1128/AAC.01550-10
33. Gicquel CP-AaB. The contribution of molecular biology in diagnosing tuberculosis and detecting antibiotic resistance. www.chlaep.org.uy/descargas/ curso-tb./molecular-biology-tb%20.pdf.
34. World Health Organization Guidelines for the programmatic management of drug-resistant tuberculosis - 2011 update 2011 World Health Organization Geneva
35. M. Zimic, P. Fuentes, R.H. Gilman, A.H. Gutierrez, D. Kirwan, and P. Sheen Pyrazinoic acid efflux rate in Mycobacterium tuberculosis is a better proxy of pyrazinamide resistance Tuberculosis 92 2012 84 91 10.1016/j.tube.2011. 09.002
36. W. Shi, X. Zhang, X. Jiang, H. Yuan, J.S. Lee, C.E. Barry 3rd, H. Wang, W. Zhang, and Y. Zhang Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis Science 333 2011 1630 1632 10.1126/science.1208813
37. C.Y. Hong, F. Wang, and X.L. Liu Detection of pncA mutation associated with pyrazinamide resistance in Mycobacterium tuberculosis by high-resolution melting cure analysis Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chin J Tuberculosis Respir Dis 36 2013 198 201